KN035 for dMMR/MSI-H Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE2

Conditions

Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Cancer Hospital, Peking University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Lin Shen, MD) · doctorshenlin@sina.cn · 86-010-88196340

Study leads

Lin Shen, MD
Principal Investigator
Peking Universtiy Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

GD2/PSMA Bi-specific CAR-T Cell Therapy

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Refractory Cancer · Recurrent Cancer · Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Stanford, United States · Aurora, United States

Study of AVZO-021 in Patients With Advanced Solid Tumors

Advanced Solid Tumor · HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Haven, United States · Sarasota, United States

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Advanced Solid Tumor · High Grade Serous Adenocarcinoma of Ovary · Squamous Non-small-cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Newport Beach, United States